Clinical Trials Logo

Filter by:
NCT ID: NCT04249362 Completed - Clinical trials for Non-small Cell Lung Cancer

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

DUART
Start date: November 26, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase II open-label, single-arm, multicenter, international study to evaluate the clinical activity of durvalumab in patients with Stage III unresectable NSCLC who are deemed to be ineligible for chemotherapy per Investigator assessment. Patients will be enrolled into 2 cohorts according to radiotherapy pretreatment dose (Cohort A: standard radiation therapy [60 gray (Gy) ± 10% or hypofractionated bioequivalent dose (BED)]; Cohort B: palliative radiation therapy [40 to < 54 Gy or hypofractionated BED])

NCT ID: NCT04248972 Completed - Chronic Pain Clinical Trials

Effects of Photobiomodulation in a Population Suffering From Fibromyalgia

Start date: January 30, 2021
Phase: N/A
Study type: Interventional

The development of an integral and global treatment to improve the quality of life in those with fibromyalgia syndrome (FMS) is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.

NCT ID: NCT04247464 Completed - Fasting Clinical Trials

Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients

CHEMOFAST
Start date: September 23, 2020
Phase: N/A
Study type: Interventional

This study will evaluate the ability of short-term fasting to reduce chemotherapy toxicity and enhance anti-tumour response in patients with colorectal carcinoma subjected to chemotherapy.

NCT ID: NCT04246489 Completed - Clinical trials for Uterine Cervical Neoplasms

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

Start date: March 30, 2020
Phase: Phase 2
Study type: Interventional

The main purpose of this study was to evaluate clinical efficacy and safety of bintrafusp alfa in participants with advanced, unresectable cervical cancer with disease progression during or after platinum-containing chemotherapy.

NCT ID: NCT04246216 Completed - Clinical trials for Carpal Tunnel Syndrome

Percutaneous Electrical Nerve Stimulation for Carpal Tunnel Syndrome

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

There is evidence supporting that physical therapy interventions can be effective for the management of patients with CTS. No consensus on the best approach exist. It seems clear that the median nerve is affected in several ways (compression, inflammation, excursion) in carpal tunnel syndrome. Percutaneous Electrical Nerve Stimulation is a treatment approach consisting of the application of an electrical current throughout needling filaments placed close to the nerve, in this case the median nerve. The purpose of this clinical trial is to compare changes in function, symptom severity and the intensity of pain after the application of Percutaneous Electrical Nerve Stimulation vs. endoscopic surgery in women with CTS at short- and long-term follow-up periods.

NCT ID: NCT04246008 Completed - Clinical trials for Acute Coronary Syndrome

Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to analyse the effects of neuromuscular training on functional capacity in patients with acute coronary syndrome, compared to the classic strength training of the cardiac rehabilitation programs

NCT ID: NCT04245579 Completed - Clinical trials for Age-Related Memory Disorders

Effectiveness of a Cognitive Training Program (UMAM Method) in Elderly People Without Dementia

Start date: October 2013
Phase: N/A
Study type: Interventional

The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia. On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g. educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention. The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.

NCT ID: NCT04244149 Completed - Healthy Clinical Trials

Effect of an Exercise Bout in Plasma and Fecal Profile

MEMEX
Start date: February 20, 2020
Phase: N/A
Study type: Interventional

The aim of this project is to study the effect of a bout of exercise on the metabolomic profile of plasma and feces as well as its influence on the intestinal microbiota.

NCT ID: NCT04244110 Completed - Clinical trials for Diabetes Mellitus, Type 2

Pilot for the Analysis of Usability in the Use of the Diacare Platform for People With Type 2 DM and Their Professionals

Start date: January 17, 2020
Phase:
Study type: Observational

The objective of this study is to evaluate the usability, utility and feasibility of the Diacare platform and the ability of users to use the platform and receive valuable information from it to help address the management of type 2 diabetes outside the healthcare environment.

NCT ID: NCT04243148 Completed - Sarcopenia Clinical Trials

Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention

Start date: May 13, 2020
Phase: N/A
Study type: Interventional

This study evaluate Frailty syndrome (FS) as a common syndrome in patients with cirrhosis and it is an independent predictor of hospitalizations, falls and mortality. Identifying, treating and preventing FS can improve the prognosis and quality of life of these patients and reduce health costs.